{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:45:01Z","timestamp":1792269901766,"version":"4.4.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010892","name":"Department of Science and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010892","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ejphar.2015.10.033","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:57:41Z","timestamp":1445907461000},"page":"33-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Antidepressants for neuroprotection in Huntington's disease: A review"],"prefix":"10.1016","volume":"769","author":[{"given":"Sumit","family":"Jamwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ejphar.2015.10.033_bib1","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","article-title":"Beta-Catenin is a target for the ubiquitin-proteasome pathway","volume":"16","author":"Aberle","year":"1997","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.ejphar.2015.10.033_bib2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1124\/pr.111.005108","article-title":"Brain-derived neurotrophic factor and neuropsychiatric disorders","volume":"64","author":"Autry","year":"2012","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.ejphar.2015.10.033_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0278-5846(00)00115-9","article-title":"Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder","volume":"24","author":"Bayer","year":"2000","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6592","key":"10.1016\/j.ejphar.2015.10.033_bib4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/382638a0","article-title":"Functional interaction of b-catenin with the transcription factor LEF-1","volume":"382","author":"Behrens","year":"1996","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.ejphar.2015.10.033_bib8","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00018-006-6242-0","article-title":"Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies","volume":"63","author":"Borrell-Pages","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2015.10.033_bib10","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":"3-Nitropropionic acid and Malonate: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease","volume":"95","author":"Brouillet","year":"2005","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.ejphar.2015.10.033_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-510X(85)90112-1","article-title":"Distribution of phosphate activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gammaglutamyl transpeptidase in post mortem brain from Huntington's disease and agonal cases","volume":"67","author":"Butterworth","year":"1985","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.ejphar.2015.10.033_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jnnp.40.6.581","article-title":"Biochemical aspects of Huntington's chorea","volume":"40","author":"Caraceni","year":"1977","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.ejphar.2015.10.033_bib14","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1083\/jcb.201002049","article-title":"Exosome release of b-catenin: a novel mechanism that antagonizes Wnt signalling","volume":"190","author":"Chairoungdua","year":"2010","journal-title":"J. Cell. Biol."},{"issue":"4","key":"10.1016\/j.ejphar.2015.10.033_bib16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(01)01083-6","article-title":"Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication","volume":"50","author":"Chen","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.ejphar.2015.10.033_bib17","first-page":"135","article-title":"Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease","volume":"34","author":"Chen","year":"2011","journal-title":"Chang Gung Med. J."},{"issue":"2","key":"10.1016\/j.ejphar.2015.10.033_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2174\/1573400054065587","article-title":"Neurotrophic actions of mood-stabilizers: a recent research discovery and its potential clinical applications","volume":"1","author":"Chen","year":"2005","journal-title":"Curr. Psychiatry Rev."},{"issue":"3","key":"10.1016\/j.ejphar.2015.10.033_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.yco.0000218604.63463.cd","article-title":"The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers","volume":"19","author":"Chen","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.10.033_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnins.2013.00114","article-title":"Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility","volume":"7","author":"Chen","year":"2013","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.ejphar.2015.10.033_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12031-008-9122-2","article-title":"Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate","volume":"37","author":"Creson","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2015.10.033_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuroscience.2012.11.061","article-title":"Acute antidepressant treatment differently modulates ERK\/MAPK activation in neurons and astrocytes of the adult mouse prefrontal cortex","volume":"232","author":"Di Benedetto","year":"2013","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.ejphar.2015.10.033_bib23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0166-2236(90)90111-M","article-title":"Excitotoxic injury of the neostriatum: a model for Huntington's disease","volume":"13","author":"DiFiglia","year":"1990","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.ejphar.2015.10.033_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.conb.2013.01.011","article-title":"Genetic approaches for understanding the role of serotonin receptors in mood and behavior","volume":"23","author":"Donaldson","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"issue":"3","key":"10.1016\/j.ejphar.2015.10.033_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","article-title":"Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington\u2019s disease","volume":"30","author":"Duan","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00018-012-1020-7","article-title":"Depression and treatment response: dynamic interplay of signalling pathways and altered neural processes","volume":"70","author":"Duric","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"issue":"50","key":"10.1016\/j.ejphar.2015.10.033_bib29","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1523\/JNEUROSCI.3455-07.2007","article-title":"Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease","volume":"27","author":"Fernandes","year":"2007","journal-title":"J. Neurosci."},{"issue":"14","key":"10.1016\/j.ejphar.2015.10.033_bib30","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMra022366","article-title":"Apoptosis and caspases in neurodegenerative diseases","volume":"348","author":"Friedlander","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.10.033_bib31","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1038\/ncomms5992","article-title":"Deficient Wnt signalling triggers striatal synaptic degeneration and impaired motor behaviour in adult mice","volume":"5","author":"Galli","year":"2014","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.ejphar.2015.10.033_bib33","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanism of neurodegeneration in Huntington's dinase","volume":"27","author":"Gill","year":"2008","journal-title":"Eur. J. Neurosci."},{"issue":"14","key":"10.1016\/j.ejphar.2015.10.033_bib34","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1038\/emboj.2010.117","article-title":"Mutant huntingtin\u2010impaired degradation of \u03b2\u2010catenin causes neurotoxicity in Huntington's disease","volume":"29","author":"Godin","year":"2010","journal-title":"EMBO"},{"issue":"32","key":"10.1016\/j.ejphar.2015.10.033_bib35","doi-asserted-by":"crossref","first-page":"22429","DOI":"10.1074\/jbc.R600015200","article-title":"Wnt signalling: multiple pathways, multiple receptors, and multiple transcription factors","volume":"281","author":"Gordon","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ejphar.2015.10.033_bib36","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington\u2019s disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"12","key":"10.1016\/j.ejphar.2015.10.033_bib37","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.mp.4002075","article-title":"Is it time to reassess the BDNF hypothesis of depression?","volume":"12","author":"Groves","year":"2007","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.ejphar.2015.10.033_bib38","doi-asserted-by":"crossref","first-page":"a008094","DOI":"10.1101\/cshperspect.a008094","article-title":"Wnt signalling and forebrain development","volume":"4","author":"Harrison-Uy","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"47","key":"10.1016\/j.ejphar.2015.10.033_bib39","doi-asserted-by":"crossref","first-page":"29405","DOI":"10.1016\/S0021-9258(18)43893-8","article-title":"Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not","volume":"269","author":"Hausladen","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ejphar.2015.10.033_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.31887\/DCNS.2009.11.3\/jhunsberger","article-title":"The neurotrophic and neuroprotective effects of psychotropic agents","volume":"11","author":"Hunsberger","year":"2009","journal-title":"Dialog-Clin. Neurosci."},{"issue":"6090","key":"10.1016\/j.ejphar.2015.10.033_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1126\/science.1222879","article-title":"Structural basis of Wnt recognition by Frizzled","volume":"337","author":"Janda","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1602\/neurorx.1.1.128","article-title":"The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration","volume":"1","author":"Leegwater-Kim","year":"2004","journal-title":"NeuroRx"},{"issue":"11","key":"10.1016\/j.ejphar.2015.10.033_bib46","first-page":"880","article-title":"Neuroprotective Effects of MK-801 against intra-striatal quinolinic acid induced behavioural, oxidative stress and cellular alteration in rats","volume":"47","author":"Kalonia","year":"2009","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.ejphar.2015.10.033_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainres.2010.11.060","article-title":"Attenuation of pro-inflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington's like alteration in rats","volume":"1372","author":"Kalonia","year":"2011","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.ejphar.2015.10.033_bib48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pnpbp.2011.01.003","article-title":"Licofelone attenuates quinolinic acid induced Huntington's like symptoms: possible behavioural, biochemical and cellular alterations","volume":"35","author":"Kalonia","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.10.033_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnmol.2011.00044","article-title":"Functions of GSK-3\u03b2 signalling in development of the nervous system","volume":"4","author":"Kim","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2015.10.033_bib50","first-page":"14","article-title":"Oppositional effects of serotonin receptors 5-HT1a, 2, and 2c in the regulation of adult hippocampal neurogenesis","volume":"3","author":"Klempin","year":"2010","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.ejphar.2015.10.033_bib51","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10571-005-8468-z","article-title":"Enhanced BDNF signalling is associated with an antidepressant-like behavioral response and changes in brain monoamines","volume":"25","author":"Koponen","year":"2005","journal-title":"Cell. Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.ejphar.2015.10.033_bib52","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1176\/appi.ajp.157.9.1445","article-title":"Gender differences in treatment response to sertraline versus imipramine in chronic depression","volume":"157","author":"Kornstein","year":"2014","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.ejphar.2015.10.033_bib54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5214\/ans.0972.7531.2006.130204","article-title":"Protective effects of antioxidants on 3-NP induced oxidative stress and cognitive impairment","volume":"13","author":"Kumar","year":"2006","journal-title":"Anna. Neurosci."},{"issue":"5\u20136","key":"10.1016\/j.ejphar.2015.10.033_bib55","first-page":"485","article-title":"Effects of resveratrol on 3-NP induced neurotoxicity, an animal model of Huntington's disease: possible neuroprotective mechanism","volume":"17","author":"Kumar","year":"2007","journal-title":"Behav. Pharm."},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1358\/mf.2007.29.1.1063492","article-title":"Possible neuroprotective mechanism of curcumin in attenuating 3-NP acid induced neurotoxicity","volume":"29","author":"Kumar","year":"2007","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2015.10.033_bib58","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/10286020902862194","article-title":"Sesamol attenuates 3- Nitropropionic Acid induced Huntington like behaviour, biochemical and cellular alterations in rats","volume":"11","author":"Kumar","year":"2009","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"19\u201320","key":"10.1016\/j.ejphar.2015.10.033_bib59","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.lfs.2009.10.001","article-title":"Lycopene modulates nitric oxide pathways against-Nitropropionic Acid induced neurotoxicity","volume":"85","author":"Kumar","year":"2009","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib60","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pnpbp.2008.10.013","article-title":"Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain","volume":"33","author":"Kumar","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.ejphar.2015.10.033_bib64","first-page":"715","article-title":"Protective role of sertraline against 3-Nitropropionic Acid induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain","volume":"47","author":"Kumar","year":"2009","journal-title":"Indian J. Exp. Biol."},{"issue":"3","key":"10.1016\/j.ejphar.2015.10.033_bib65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/FBP.0b013e32833a5bf4","article-title":"Nitric oxide mechanism in the protective effects of antidepressants against 3-Nitropropionic acid induced cognitive deficit, glutathione and mitochondrial alteration in animal model of Huntington's disease","volume":"21","author":"Kumar","year":"2010","journal-title":"Behav. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejphar.2015.10.033_bib66","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1177\/0269881110364269","article-title":"Novel protective mechanisms of antidepressants against 3-nitroproprionic acid induced Huntington's-like symptoms: a comparative study","volume":"25","author":"Kumar","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"2b","key":"10.1016\/j.ejphar.2015.10.033_bib67","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","article-title":"Role of LOX\/COX pathways in 3-Nitropropionic acid induced HD like symptoms in rats: protective role of lycofelone","volume":"164","author":"Kumar","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejphar.2015.10.033_bib68","doi-asserted-by":"crossref","first-page":"22558","DOI":"10.3390\/ijms141122558","article-title":"Neuroprotective effects of psychotropic drugs in Huntington's disease","volume":"14","author":"Lauterbach","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.ejphar.2015.10.033_bib70","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/hmg\/9.19.2859","article-title":"Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis","volume":"9","author":"Li","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"7113","key":"10.1016\/j.ejphar.2015.10.033_bib71","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.ejphar.2015.10.033_bib74","doi-asserted-by":"crossref","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","article-title":"Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus","volume":"20","author":"Malberg","year":"2000","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.ejphar.2015.10.033_bib75","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1385\/JMN:24:2:207","article-title":"MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes","volume":"24","author":"Mercier","year":"2004","journal-title":"J. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.ejphar.2015.10.033_bib76","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/sj.npp.1301497","article-title":"Genetic regulation of behavioral and neuronal responses to fluoxetine","volume":"33","author":"Miller","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"29","key":"10.1016\/j.ejphar.2015.10.033_bib77","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.1073\/pnas.0402141101","article-title":"Essential role of brain-derived neurotrophic factor in adult hippocampal function","volume":"101","author":"Monteggia","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.ejphar.2015.10.033_bib78","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biopsych.2006.03.021","article-title":"Brain-Derived neurotrophic factor conditional knock outs show gender differences in depression related behaviors","volume":"61","author":"Monteggia","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib79","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2008.04.012","article-title":"A role for nuclear beta-catenin in SNRI antidepressant-induced hippocampal cell proliferation","volume":"55","author":"Mostany","year":"2008","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.ejphar.2015.10.033_bib80","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1523\/JNEUROSCI.16-07-02365.1996","article-title":"Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus","volume":"16","author":"Nibuya","year":"1996","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.ejphar.2015.10.033_bib82","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0006-8993(91)91640-M","article-title":"MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system","volume":"539","author":"Pan","year":"1991","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.ejphar.2015.10.033_bib83","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/hmg\/ddn385","article-title":"Altered serotonin receptor expression is associated with depression related behavior in the R6\/1 transgenic mouse model of Huntington's disease","volume":"18","author":"Pang","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib84","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","article-title":"The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2Huntington's disease mouse model","volume":"210","author":"Peng","year":"2008","journal-title":"Exp. Neurol."},{"issue":"4b","key":"10.1016\/j.ejphar.2015.10.033_bib85","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1476-5381.2011.01516.x","article-title":"Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain\u2010derived neurotrophic factor, <beta>\u2010catenin and antidepressant\u2010like effects","volume":"165","author":"Pilar\u2010Cu\u00e9llar","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.10.033_bib86","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fnbeh.2014.00135","article-title":"Mood disorders in Huntington Disease: from behaviour to cellular and molecular mechanism","volume":"8","author":"Pla","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"9","key":"10.1016\/j.ejphar.2015.10.033_bib1000","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington's disease: A systematic review and meta\u2010analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.ejphar.2015.10.033_bib87","doi-asserted-by":"crossref","unstructured":"Przedborski, S., 2007. Neuroinflammation and Parkinson's disease. In: Vinken, P.J., Bruyn, G.W., (Eds), Handb Clin Neurol. 83, pp. 535\u2013551.","DOI":"10.1016\/S0072-9752(07)83026-0"},{"issue":"10","key":"10.1016\/j.ejphar.2015.10.033_bib88","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/sj.npp.1301345","article-title":"Pharmacologically diverse antidepressants rapidly activate brain derived neurotrophic factor receptor TrkB and induce phospholipase-C gamma signalling pathways in mouse brain","volume":"32","author":"Rantamaki","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.ejphar.2015.10.033_bib89","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.psym.2011.12.010","article-title":"Psychiatric disorders in Huntington's disease: a 2-year follow up study","volume":"53","author":"Reedeker","year":"2012","journal-title":"Psychosomatics"},{"issue":"7","key":"10.1016\/j.ejphar.2015.10.033_bib90","doi-asserted-by":"crossref","first-page":"e22133","DOI":"10.1371\/journal.pone.0022133","article-title":"Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's Disease and depression","volume":"6","author":"Renoir","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ejphar.2015.10.033_bib91","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1476-5381.2011.01567.x","article-title":"Treatment of depressive like behaviour in Huntington's disease mice by chronic sertraline and exercise","volume":"165","author":"Renoir","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"5448","key":"10.1016\/j.ejphar.2015.10.033_bib92","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1126\/science.286.5448.2358","article-title":"Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons","volume":"286","author":"Riccio","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2015.10.033_bib93","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainres.2010.11.020","article-title":"Upregulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography","volume":"1370","author":"Richards","year":"2011","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib94","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1523\/JNEUROSCI.23-01-00349.2003","article-title":"Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant induced behavioral effects","volume":"23","author":"Saarelainen","year":"2003","journal-title":"J. Neurosci."},{"issue":"3\u20134","key":"10.1016\/j.ejphar.2015.10.033_bib95","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000331912","article-title":"Huntington's disease: current epidemiology and pharmacological management in UK primary care","volume":"37","author":"Sackley","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.ejphar.2015.10.033_bib96","first-page":"a008003","article-title":"Wnt signalling in the vertebrate central nervous system: from axon guidance to synaptic function. Cold Spring Harb Perspect","volume":"4","author":"Salinas","year":"2012","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","article-title":"Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions","volume":"95","author":"Saudou","year":"1998","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ejphar.2015.10.033_bib98","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","article-title":"Brain derived neurotrophic factor produces antidepressant effects in behavioral models of depression","volume":"22","author":"Shirayama","year":"2002","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.ejphar.2015.10.033_bib100","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington's disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0091-3057(96)00169-4","article-title":"Antidepressant-like effects of brain-derived neurotrophic factor (BDNF)","volume":"56","author":"Siuciak","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib103","first-page":"135","article-title":"Abnormal mitochondrial dynamics and neurodegenerative diseases","volume":"1802","author":"Su","year":"2010","journal-title":"Biochem. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib104","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.ejphar.2015.10.033_bib106","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signalling and apoptosis of medium spiny neurons in Huntington\u2019s disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.ejphar.2015.10.033_bib107","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0896-6273(00)81010-7","article-title":"Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism","volume":"20","author":"Tao","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2015.10.033_bib108","series-title":"Boca Raton (FL)","first-page":"2008","article-title":"Biology of the NMDA Receptor","author":"Van Dongen","year":"2008"},{"key":"10.1016\/j.ejphar.2015.10.033_bib110","series-title":"Advances in Research on Neurodegeneration","first-page":"1","article-title":"Huntington disease: new insights on the role of huntingtin cleavage","author":"Wellington","year":"2000"},{"issue":"18","key":"10.1016\/j.ejphar.2015.10.033_bib111","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.22-18-07862.2002","article-title":"Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington\u2019s disease","volume":"22","author":"Wellington","year":"2002","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.ejphar.2015.10.033_bib112","first-page":"a007864","article-title":"Wnt proteins. Cold Spring Harb","volume":"4","author":"Willert","year":"2012","journal-title":"Perspect. Biol."},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib113","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0166-4328(96)00106-4","article-title":"Characterization of 3HGR113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders","volume":"73","author":"Wong","year":"1995","journal-title":"Behav. Brain Res."},{"issue":"5","key":"10.1016\/j.ejphar.2015.10.033_bib116","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/hipo.20658","article-title":"Wheel running and environmental enrichment differentially modify exon specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice","volume":"20","author":"Zajac","year":"2010","journal-title":"Hippocampus"},{"issue":"2","key":"10.1016\/j.ejphar.2015.10.033_bib117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for huntington's disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib118","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","article-title":"Mutant huntingtin enhances excitotoxic cell death","volume":"17","author":"Zeron","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.ejphar.2015.10.033_bib119","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.ejphar.2015.10.033_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1460-9568.2010.7483.x","article-title":"The Wnt\/b-catenin signalling pathway in the adult neurogenesis","volume":"33","author":"Zhang","year":"2011","journal-title":"Eur. J. Neurosci. B"},{"issue":"6","key":"10.1016\/j.ejphar.2015.10.033_bib121","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.ejphar.2015.10.033_bib122","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1371\/journal.pone.0022966","article-title":"Brain-derived neurotrophic factor in patients with Huntington\u2019s disease","volume":"6","author":"Zuccato","year":"2011","journal-title":"PLoS One"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915303149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915303149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T01:26:29Z","timestamp":1718155589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915303149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":96,"alternative-id":["S0014299915303149"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.10.033","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressants for neuroprotection in Huntington's disease: A review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}